453 related articles for article (PubMed ID: 24071464)
21. Blood cells: an historical account of the roles of purinergic signalling.
Burnstock G
Purinergic Signal; 2015 Dec; 11(4):411-34. PubMed ID: 26260710
[TBL] [Abstract][Full Text] [Related]
22. Platelet shape change and Ca2+ mobilization induced by collagen, but not thrombin or ADP, are inhibited by phenylarsine oxide.
Greenwalt DE; Tandon NN
Br J Haematol; 1994 Dec; 88(4):830-8. PubMed ID: 7819106
[TBL] [Abstract][Full Text] [Related]
23. Adenosine Diphosphate Improves Wound Healing in Diabetic Mice Through P2Y
Borges PA; Waclawiak I; Georgii JL; Fraga-Junior VDS; Barros JF; Lemos FS; Russo-Abrahão T; Saraiva EM; Takiya CM; Coutinho-Silva R; Penido C; Mermelstein C; Meyer-Fernandes JR; Canto FB; Neves JS; Melo PA; Canetti C; Benjamim CF
Front Immunol; 2021; 12():651740. PubMed ID: 33828561
[TBL] [Abstract][Full Text] [Related]
24. Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor.
Shi XP; Yin KC; Gardell SJ
Thromb Res; 1995 Feb; 77(3):235-47. PubMed ID: 7740516
[TBL] [Abstract][Full Text] [Related]
25. Occupancy of P2 purinoceptors with unique properties modulates the function of human platelets.
Soslau G; Brodsky I; Parker J
Biochim Biophys Acta; 1993 Jun; 1177(2):199-207. PubMed ID: 7684612
[TBL] [Abstract][Full Text] [Related]
26. Interactions of nucleoside di- and triphosphates with rabbit platelets.
Packham MA; Guccione MA; Perry DW; Mustard JF
Am J Physiol; 1974 Nov; 227(5):1143-8. PubMed ID: 4440755
[No Abstract] [Full Text] [Related]
27. Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline.
Holmsen H; Day HJ; Setkowsky CA
Biochem J; 1972 Aug; 129(1):67-82. PubMed ID: 4675006
[TBL] [Abstract][Full Text] [Related]
28. Preparation of a mixture of nucleoside triphosphates suitable for use in synthesis of nucleotide phosphate sugars from ribonucleic acid using nuclease P1, a mixture of nucleoside monophosphokinases and acetate kinase.
Haynie SL; Whitesides GM
Appl Biochem Biotechnol; 1990 Mar; 23(3):205-20. PubMed ID: 1693485
[TBL] [Abstract][Full Text] [Related]
29. Aggregin: a platelet ADP receptor that mediates activation.
Colman RW
FASEB J; 1990 Mar; 4(5):1425-35. PubMed ID: 2407587
[TBL] [Abstract][Full Text] [Related]
30. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets.
Holmsen H; Setkowsky CA; Day HJ
Biochem J; 1974 Nov; 144(2):385-96. PubMed ID: 4462589
[TBL] [Abstract][Full Text] [Related]
31. Exploring bias in platelet P2Y
Pan D; Ladds G; Rahman KM; Pitchford SC
Br J Pharmacol; 2024 Feb; 181(4):580-592. PubMed ID: 37442808
[TBL] [Abstract][Full Text] [Related]
32. Subclasses of purinoceptors in feline bladder.
Theobald RJ
Eur J Pharmacol; 1992 Dec; 229(2-3):125-30. PubMed ID: 1490515
[TBL] [Abstract][Full Text] [Related]
33. Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2y-purinergic receptor.
Cooper CL; Morris AJ; Harden TK
J Biol Chem; 1989 Apr; 264(11):6202-6. PubMed ID: 2495280
[TBL] [Abstract][Full Text] [Related]
34. Identification of ecto-nucleoside triphosphate pyrophosphatase in human articular chondrocytes in monolayer culture.
Caswell AM; Russell RG
Biochim Biophys Acta; 1985 Oct; 847(1):40-7. PubMed ID: 2996615
[TBL] [Abstract][Full Text] [Related]
35. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
36. The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.
Macfarlane DE; Mills DC
Blood; 1975 Sep; 46(3):309-20. PubMed ID: 167888
[TBL] [Abstract][Full Text] [Related]
37. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
[TBL] [Abstract][Full Text] [Related]
38. ATP antagonizes thrombin-induced signal transduction through 12(S)-HETE and cAMP.
Burzaco J; Conde M; Parada LA; Zugaza JL; Dehaye JP; Marino A
PLoS One; 2013; 8(6):e67117. PubMed ID: 23826207
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological characterization of P2Y receptor subtypes - an update.
von Kügelgen I
Purinergic Signal; 2024 Apr; 20(2):99-108. PubMed ID: 37697211
[TBL] [Abstract][Full Text] [Related]
40. Platelet ADP receptor and alpha 2-adrenoreceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding.
Figures WR; Scearce LM; Wachtfogel Y; Chen J; Colman RF; Colman RW
J Biol Chem; 1986 May; 261(13):5981-6. PubMed ID: 3009439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
